<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did DLB's licensing revenue trend in Q1 2025 compared to previous quarters?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/14/2025 12:21am
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Dolby Laboratories (DLB) saw a notable increase in licensing revenue in Q1 2025, reaching $1.18 billion, up from $330.48 million in the same quarter of the previous year, 2024. This indicates a strong recovery or growth in the licensing segment, which contributed significantly to the overall revenue of the company during that period.



</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:F,comeFrom:"AInvestShareLink",events:[],answerSource:o}],fetch:{},error:p,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:i,agent_id:a,output_media_info:[],task_id:a,language:a,source:o,cache_builder:a,reply_action:"Answer",execute_mode:z,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did DLB's licensing revenue trend in Q1 2025 compared to previous quarters?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did DLB's licensing revenue trend in Q1 2025 compared to previous quarters?\",\"user_id\":\"dp64190794\",\"user_name\":\"\",\"trace_id\":\"00d82724-f2c5-49c5-a8ee-0b00606268ef\",\"session_id\":\"00d82724-f2c5-49c5-a8ee-0b00606268ef\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:G,query_type:l,text:"2 results found:\n|stock code|stock name|Last Price|Last Change|Revenue by Segment[20250331]|Report End Date|Segment Name|\n|---|---|---|---|---|---|---|\n|DLB|Dolby Laboratories|$73.38|1.13%|1.18 billion||Licensing|\n|DLB|Dolby Laboratories|$73.38|1.13%|330.48 million||Licensing|\n",query_data:{number:i,title:A,query_type:l,condition:a,model_sql:H,data_ext_params:{merge_repeat:c,expand_index:b,data_add:i,add_index:e}}},{info_type:G,query_type:l,text:"3 results found:\n|stock code|stock name|Last Price|Last Change|Revenue by Segment[20241231]|Report End Date|Segment Name|\n|---|---|---|---|---|---|---|\n|DLB|Dolby Laboratories|$73.38|1.13%|1.18 billion||Licensing|\n|DLB|Dolby Laboratories|$73.38|1.13%|899.09 million||Licensing|\n|DLB|Dolby Laboratories|$73.38|1.13%|330.48 million||Licensing|\n",query_data:{number:I,title:B,query_type:l,condition:a,model_sql:J,data_ext_params:{merge_repeat:c,expand_index:b,data_add:i,add_index:e}}}],answer_chain_name:K,agent_mode:L,native_answer:a,come_from:a,text_answer:F,trace_id:j,cost:17181,event_names:a,question:g,fallback_type:M,input_type:N,fall_back_reason:{fall_back_type:M,risk_detail:{matched_words:[]}},session_id:j,first_return_cost:3156,cache_type:a,question_id:j,transfer_question:g,signal_type:"ON_COMPLETE",start_time:O,remote_svc:o,slots:[],answer_type:z,user_id:x,skill_name:C},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:j,session_id:j,user_id:x,question:g,source:o,raw_question:g,version:"3.4.1",action_name:C,nlu:{entity:[{type:P,value:"DLB.N",market:Q}]},deep_research:c,deep_thinking:c,agent_mode:L},extra:{}},{answer_path:q,section:{id:r,info_texts:["Thinking"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:q,section:{id:r,info_texts:["Querying Stock: DLB Licensing Revenue in Q1 2025"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:R},logs:[],extra:{action:S,action_input:A,thought:T}},{answer_path:q,section:{id:r,info_texts:["Querying Stock: DLB Licensing Revenue in Q4 2024"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:R},logs:[],extra:{action:S,action_input:B,thought:T}},{answer_path:d,section:{id:h,info_texts:[],show_type:f,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:f,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:q,section:{id:r,info_texts:["Generating Answer"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,voice_txt:"D",text_answer:U,rich_text:U,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:V,info_texts:[],show_type:k,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:A,query_type:l,trace_data:a,index:i,model_sql:H,data_ext_params:{merge_repeat:c,expand_index:b,data_add:i,add_index:e},jump_type:W}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,voice_txt:a,text_answer:X,rich_text:X,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:V,info_texts:[],show_type:k,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:B,query_type:l,trace_data:a,index:I,model_sql:J,data_ext_params:{merge_repeat:c,expand_index:b,data_add:i,add_index:e},jump_type:W}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,voice_txt:". This",text_answer:Y,rich_text:Y,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:f,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"DLB",market_id:Q,name:Z,domain:P},pos:e,section_id:m,txt:Z,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:f,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:f,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,voice_txt:"\n",text_answer:_,rich_text:_,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:f,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:f,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:h,info_texts:[],show_type:f,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:k,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:q,section:{id:r,info_texts:["Completed"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:t,query_text:t,trace_info:{item_id:"d7c9e88b4a2dd0f757073f40a86d1b5d",item_type:n,item_name:t,rec_info:$}},{display_text:u,query_text:u,trace_info:{item_id:"7b1d218d2dedf714de4fbc6e5172a2dd",item_type:n,item_name:u,rec_info:aa}},{display_text:v,query_text:v,trace_info:{item_id:"f3bd2b40018ac975849400934a4578f0",item_type:n,item_name:v,rec_info:ab}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:ac,related_name:ad}],puuid:D,tag:a,category:"custom",uuid:ae}],global:{urp_static_data:[{name:ad,value:{status_code:e,columns:[{type:w,index_name:af,key:af},{type:w,index_name:ag,key:ag},{type:w,index_name:ah,key:ah},{type:w,index_name:ai,key:ai},{type:w,index_name:aj,key:aj}],datas:[{send_text:t,item_type:n,rec_info:$,display_text:t,rec_reason:a},{send_text:u,item_type:n,rec_info:aa,display_text:u,rec_reason:a},{send_text:v,item_type:n,rec_info:ab,display_text:v,rec_reason:a}],dataSize:ac,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:ak,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:y,"min-height":"100%",position:al,height:y},isMaterial:c,id:ak,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:E,componentUuid:ae,script:[{name:am,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:E,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:E},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:y,position:al,height:y},isMaterial:b,_id:19,id:am,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:an,voice_txt:a,tracking_info:{},uuid:D},order:{is_auto:c,render_for:an,chart_type:"command",puuid:D}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:f,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:C,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:z,answer_chain_name:K},is_deep_research:c,deep_thinking:c,create_time:1744604478085},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:p,docsData:[],quoteData:p},tplType:"question"},events:ao,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:ao,client_ip:a,question:g,user_id:x,user_name:a,trace_id:j,session_id:j,source:o,input_type:N}}],userId:x,userName:a,startTime:O,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:p,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:p,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-dlbs-licensing-revenue-trend-in-q1-2025-compared-to-previous-quarters-a9c486\u002F",config:{_app:{basePath:ap,assetsPath:ap,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,"signal","How did DLB's licensing revenue trend in Q1 2025 compared to previous quarters?",999,1,"00d82724-f2c5-49c5-a8ee-0b00606268ef","rich_text","intusstock",2001,"llm_generated","ths_ainvest_lite_web",null,"progress\u002Fsearching_for",1000,"searching_for","What was the trend in DLB's licensing revenue across previous quarters?","What was DLB's licensing revenue in Q1 2025?","How did DLB's Q1 2025 licensing revenue compare to Q4 2024?","STR","dp64190794","auto","agent","DLB Licensing Revenue in Q1 2025","DLB Licensing Revenue in Q4 2024","inspect stocks","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Dolby Laboratories (DLB) saw a notable increase in licensing revenue in Q1 2025, reaching $1.18 billion, up from $330.48 million in the same quarter of the previous year, 2024. This indicates a strong recovery or growth in the licensing segment, which contributed significantly to the overall revenue of the company during that period.\n\n\n\n","query_data","select   stock_code,   revenue_by_segment from   ustock_rev_comp where   report_end_date = date('2025y1q')   and stock_code = 'DLB.N'   and segment_name = 'Licensing'",2,"select   stock_code,   revenue_by_segment from   ustock_rev_comp where   report_end_date = date('2024y4q')   and stock_code = 'DLB.N'   and segment_name = 'Licensing'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1744604460904,"stock","169","thinking","Querying Stock","The user wants to compare the Q1 2025 licensing revenue performance of DLB with the previous quarter's licensing revenue. I should focus on the licensing revenue data for Q1 2025 and the previous quarter. I will use FinQuery for the data mentioned above.","Dolby Laboratories (DLB) saw a notable increase in licensing revenue in Q1 2025, reaching $1.18 billion, up from $330.48 million in the same quarter of the previous year, 2024[^1]",2000,"data_query","[^2]",". This indicates a strong recovery or growth in the licensing segment, which contributed significantly to the overall revenue of the company during that period.\n\n","Dolby Laboratories","\n``` visual\n{\"uuid\":\"884a3ef6-e739-4efb-9af8-2a1257816401\"}\n```\n","2+679_496_21_554+0+0+00d82724-f2c5-49c5-a8ee-0b00606268ef+d7c9e88b4a2dd0f757073f40a86d1b5d+llm_generated+aimeTagAnalysis+0+0.08881637454032898+1","2+679_496_21_554+0+0+00d82724-f2c5-49c5-a8ee-0b00606268ef+7b1d218d2dedf714de4fbc6e5172a2dd+llm_generated+aimeTagAnalysis+0+0.08463239669799805+2","2+679_496_21_554+0+0+00d82724-f2c5-49c5-a8ee-0b00606268ef+f3bd2b40018ac975849400934a4578f0+llm_generated+aimeTagAnalysis+0+0.06369754672050476+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>